Yourgene Health PLC
LSE:YGEN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| UK |
|
Yourgene Health PLC
LSE:YGEN
|
16.4m GBP |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
189.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
190.1B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
138.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.1B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.6B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.1B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.5B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
56B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.3B USD |
Loading...
|
Market Distribution
| Min | -188 120% |
| 30th Percentile | 0% |
| Median | 0% |
| 70th Percentile | 0.1% |
| Max | 10 443.9% |
Other Profitability Ratios
Yourgene Health PLC
Glance View
Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. The principal activity of the Company is that of a molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for prenatal screening and other clinical applications in the early detection, monitoring and treatment of disease. The firm operates through two segments. The Genomic Technologies segment provides the in vitro diagnostic products, software and instrumentation manufactured by the Company and distributed globally through its direct and indirect sales channels. The Genomic Services segment operates testing laboratories in Taiwan and the United Kingdom and provides services to clinicians, third party clinical service providers and contract research organizations. These services require similar technical, commercial and managerial competences in the two host countries, and sometimes consume the output from the Genomic Technologies segment.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 3 years, Yourgene Health PLC’s Net Margin has decreased from 42.6% to -27.6%. During this period, it reached a low of -66.6% on Mar 31, 2021 and a high of 42.6% on Aug 30, 2019.